Italy’s Sunshine Act: Implementation Advances After Three-Year Wait
After its passage in June 2022, Italy’s Sunshine Act (Law 62/2022) is finally moving toward implementation—marking a significant development in life sciences transparency. The law introduces mandatory reporting obligations for financial relationships between life sciences companies and healthcare professionals (HCPs) or healthcare organizations (HCOs), including transfers of value (ToVs), financial interests, and service agreements. Key [...]
Strengthening Compliance in Transparency Programs: Key Lessons from Recent DOJ Settlement (Pt. 2)
This is Part 2 in our blog series exploring a recent government enforcement action. Haven’t read Part 1 which covers speaker program compliance risks? Be sure to check it out here. Recently, the Department of Justice (DOJ) reached a settlement with a global pharmaceutical company, resolving allegations that one of its subsidiaries paid kickbacks to [...]
Strengthening Compliance in Speaker Programs: Key Lessons from Recent DOJ Settlement (Pt. 1)
Since the Office of the Inspector General (OIG) issued its Special Fraud Alert in November 2020, speaker programs have remained under intense regulatory scrutiny. Recently, the Department of Justice (DOJ) reached a settlement with a global pharmaceutical company, resolving allegations that one of its subsidiaries paid kickbacks to healthcare providers (HCPs) to drive prescriptions of [...]
Real Life Sciences: Advanced Anonymization For Clinical Trial Disclosure
MediSpend recently acquired Real Life Sciences (RLS), the leading provider of clinical data and documents anonymization and redaction for the life sciences industry. Their platform, RLS Protect, is the industry leading solution which helps trial sponsors prepare required regulatory disclosure submissions and clinical data for sharing purposes. Listen as Elliot Zimmerman, CEO of RLS, [...]
DOJ’s ECCP Updates: Navigating Whistleblower Programs and Emerging Risks
In September 2024, the Department of Justice (DOJ) released an updated version of its Evaluation of Corporate Compliance Programs (ECCP) Guidance. The ECCP serves as a framework for DOJ prosecutors to evaluate a company’s compliance program when considering the appropriate enforcement actions. While updates were made across multiple topics, the most notable changes focus on [...]
Unlocking the Value of Event Management Systems in the Life Science Industry
Pharmaceutical and medical device companies operate in a highly regulated and competitive landscape where efficient, compliant event management is essential. From medical congresses and training workshops to key opinion leader (KOL) meetings, these events shape industry relationships and drive innovation. As companies evaluate event management systems, they look for solutions that streamline processes, deliver educational [...]
DOJ’s ECCP Updates: Managing AI and Emerging Tech Risks in Compliance
In September 2024, the Department of Justice (DOJ) released an updated version of its Evaluation of Corporate Compliance Programs (ECCP) Guidance. The ECCP serves as a framework for DOJ prosecutors to evaluate a company’s compliance program when considering the appropriate enforcement actions. While updates were made across multiple topics, the most notable changes focus on [...]
MediSpend Expands Its Footprint in Governance, Risk and Compliance Solutions with Acquisition of Real Life Sciences
Portsmouth, NH – January 27, 2025 — MediSpend, a global technology company providing best-in-class solutions for the life sciences industry, announces its acquisition of Real Life Sciences (RLS), a leader in advanced anonymization solutions for clinical trial and other data. MediSpend’s second acquisition in less than a year reinforces its commitment to expanding its presence [...]
Supercharge Your KOL Relationships With MediSpend’s KOL Management Solution
In the competitive landscape of life sciences, building and nurturing strong relationships with key opinion leaders (KOLs) is crucial for success. These influential experts are at the forefront of medical innovation, driving drug advocacy and shaping the future of healthcare. Managing these relationships effectively, while ensuring full compliance, can be a complex challenge. MediSpend’s KOL [...]
How to Strengthen Relationships With KOLs Webinar
Listen as our experts discuss the importance of identifying and partnering with the right KOLs.Key topics include:Keys to a successful KOL management programHow profile data is essential to your KOL relationship strategyWhy a third-party solution is crucial for building strong relationships with KOLs